By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Merck & Co. Inc. (Form SC TO-T) was posted on June 27, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There was one document filed with this form. The SEC file number is 0001193125-14-253298.
The contact information for this company is ONE MERCK DRIVE, P.O. BOX 100, WHITEHOUSE STATION NJ 08889-0100, 908-423-1000.
Our editors provided additional information about Form SC TO-T: Tender offer statement by Third Party. Replaces SC 14D-1 as of January 2000.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1093649/0001193125-14-253298-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Merck & Co. Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC